FAP and nasopharyngeal carcinoma: These findings suggest that levels of YAP1 and FAPα might be useful as independent predictors of metastasis and that pharmaceutical interventions targeting YAP1 have the potential to break down the NPC tumor microenvironment and improve the therapeutic benefits.